Literature DB >> 7629384

Cancer in iodine-131 exposed patients.

P Hall1, L E Holm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629384     DOI： 10.1007/BF03349726

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  12 in total

1.  Cancer mortality in women with thyroid disease.

Authors:  M B Goldman; R R Monson; F Maloof
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

2.  Cancer risk in population examined with diagnostic doses of 131I.

Authors:  L E Holm; K E Wiklund; G E Lundell; N A Bergman; G Bjelkengren; U B Ericsson; E S Cederquist; M E Lidberg; R S Lindberg; H V Wicklund
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

3.  Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women.

Authors:  M B Goldman; F Maloof; R R Monson; A Aschengrau; D S Cooper; E C Ridgway
Journal:  Am J Epidemiol       Date:  1988-05       Impact factor: 4.897

4.  Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout.

Authors:  T E Hamilton; G van Belle; J P LoGerfo
Journal:  JAMA       Date:  1987-08-07       Impact factor: 56.272

5.  Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study.

Authors:  E L Saenger; G E Thoma; E A Tompkins
Journal:  JAMA       Date:  1968-09-16       Impact factor: 56.272

6.  Leukaemia incidence after iodine-131 exposure.

Authors:  P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; A Hallquist; M Lidberg; G Lundell; A Mattsson; J Tennvall
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

7.  Mortality in women treated for hyperthyroidism.

Authors:  D A Hoffman; W M McConahey; E L Diamond; L T Kurland
Journal:  Am J Epidemiol       Date:  1982-02       Impact factor: 4.897

8.  Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study.

Authors:  L E Holm; K E Wiklund; G E Lundell; N A Bergman; G Bjelkengren; E S Cederquist; U B Ericsson; L G Larsson; M E Lidberg; R S Lindberg
Journal:  J Natl Cancer Inst       Date:  1988-09-21       Impact factor: 13.506

9.  Cancer risk after iodine-131 therapy for hyperthyroidism.

Authors:  L E Holm; P Hall; K Wiklund; G Lundell; G Berg; G Bjelkengren; E Cederquist; U B Ericsson; A Hallquist; L G Larsson
Journal:  J Natl Cancer Inst       Date:  1991-08-07       Impact factor: 13.506

10.  Induction of leukemia by 131-I treatment of thyroid carcinoma.

Authors:  H Brincker; H S Hansen; A P Andersen
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640
View more
  1 in total

1.  Targeted radionuclide therapy.

Authors:  Devrim Ersahin; Indukala Doddamane; David Cheng
Journal:  Cancers (Basel)       Date:  2011-10-11       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.